Zacks Investment Management’s Phibro Animal Health PAHC Stock Holding History

Zacks Investment Management’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.21M	Buy	102,233 +5,725	+6%	+$242K	0.02%	310
2026 Q1	$5.34M	Buy	96,508 +5,117	+6%	+$244K	0.04%	217
2025 Q4	$3.41M	Buy	91,391 +10,642	+13%	+$432K	0.03%	277
2025 Q3	$3.27M	Buy	80,749 +9,361	+13%	+$309K	0.03%	272
2025 Q2	$1.82M	Buy	71,388 +9,192	+15%	+$200K	0.02%	332
2025 Q1	$1.33M	Buy	62,196 +9,974	+19%	+$223K	0.01%	374
2024 Q4	$1.1M	Buy	52,222 +40,064	+330%	+$927K	0.01%	410
2024 Q3	$274K	Buy	+12,158	New	+$235K	﹤0.01%	573

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Zacks Investment Management's PAHC Position: Q2 2026 in Review

Zacks Investment Management increased its Phibro Animal Health (PAHC) stake by 5.9% in Q2 2026, buying an estimated $242K and bringing the position to 102,233 shares worth $3.21M. The position accounts for 0.02% of the portfolio, ranked #310.

Zacks Investment Management first reported a position in PAHC in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.34M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Zacks Investment Management held 102,233 shares of Phibro Animal Health worth $3.21M as of Q2 2026.
Zacks Investment Management bought 5,725 Phibro Animal Health shares in Q2 2026, an estimated $242K.
Phibro Animal Health made up 0.02% of Zacks Investment Management's portfolio in Q2 2026, its #310 holding.
Zacks Investment Management first reported a position in Phibro Animal Health in Q3 2024 and has held it in 8 quarters since.
Zacks Investment Management's Phibro Animal Health position peaked at $5.34M in Q1 2026.
208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Zacks Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.